These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33809949)

  • 1. A Resource for the Network Representation of Cell Perturbations Caused by SARS-CoV-2 Infection.
    Perfetto L; Micarelli E; Iannuccelli M; Lo Surdo P; Giuliani G; Latini S; Pugliese GM; Massacci G; Vumbaca S; Riccio F; Fuoco C; Paoluzi S; Castagnoli L; Cesareni G; Licata L; Sacco F
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33809949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection.
    Tanaka Y; Higashihara K; Nakazawa MA; Yamashita F; Tamada Y; Okuno Y
    Sci Rep; 2021 May; 11(1):11241. PubMed ID: 34045524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
    Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
    Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
    Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
    Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
    Yousefi H; Poursheikhani A; Bahmanpour Z; Vatanmakanian M; Taheri M; Mashouri L; Alahari SK
    Biomed Pharmacother; 2020 Oct; 130():110548. PubMed ID: 33475497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of human proteins and genes involved in SARS-CoV-2 infection.
    Jahanafrooz Z; Chen Z; Bao J; Li H; Lipworth L; Guo X
    Gene; 2022 Jan; 808():145963. PubMed ID: 34530086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
    Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
    J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host proviral and antiviral factors for SARS-CoV-2.
    Lv L; Zhang L
    Virus Genes; 2021 Dec; 57(6):475-488. PubMed ID: 34510331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.
    Feng L; Yin YY; Liu CH; Xu KR; Li QR; Wu JR; Zeng R
    J Mol Cell Biol; 2020 Jun; 12(12):946-957. PubMed ID: 32642770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection.
    Salgado-Albarrán M; Navarro-Delgado EI; Del Moral-Morales A; Alcaraz N; Baumbach J; González-Barrios R; Soto-Reyes E
    NPJ Syst Biol Appl; 2021 May; 7(1):21. PubMed ID: 34031419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
    Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
    Vascul Pharmacol; 2021 Apr; 137():106823. PubMed ID: 33232769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
    Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
    EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.
    Swain O; Romano SK; Miryala R; Tsai J; Parikh V; Umanah GKE
    J Neurosci; 2021 Jun; 41(25):5338-5349. PubMed ID: 34162747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry.
    Kee J; Thudium S; Renner DM; Glastad K; Palozola K; Zhang Z; Li Y; Lan Y; Cesare J; Poleshko A; Kiseleva AA; Truitt R; Cardenas-Diaz FL; Zhang X; Xie X; Kotton DN; Alysandratos KD; Epstein JA; Shi PY; Yang W; Morrisey E; Garcia BA; Berger SL; Weiss SR; Korb E
    Nature; 2022 Oct; 610(7931):381-388. PubMed ID: 36198800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.